SHLP2

SHLP2 (Small Humanin-Like Peptide 2) is a mitochondrial-derived peptide similar to humanin. It has shown insulin-sensitizing and cytoprotective effects in research, with potential metabolic benefits.

Mechanism of Action

Enhances insulin sensitivity and glucose uptake. Provides cytoprotective effects similar to humanin. May act through similar but distinct receptor pathways.

Typical Dosage (Research)

Research compound with doses in the microgram to low milligram range studied in animal models. Human dosing not established.

Subcutaneous or intraperitoneal injection in research settings. Various SHLP analogs (1-6) have different properties.

Side Effects & Risks

Limited data. Animal studies suggest good tolerability. May affect glucose metabolism.

Highly experimental. Most data from animal models. Human safety and efficacy not established.

Who Uses SHLP2

Researchers studying mitochondrial-derived peptides, those interested in cutting-edge longevity research.